The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).

Orphan turned Isabelle Fuhrman into a horror icon. It showed her as 9-year-old Esther, who gets adopted by a married couple.

The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.

प्रकाशन अधिकारों के कारण हमारी अधिकांश सामग्री ऑस्ट्रेलिया के भीतर ही स्ट्रीम करने के लिए उपलब्ध है।.

An orphan in Victorian England falls in with a gang of pickpockets, led by the Artful Dodger and under the direction of ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...

Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

Years after becoming a horror icon as a child, the industry may not have thought of Fuhrman as a romantic lead. But, as she ...

Harris Center for The Arts will present the Tony Award-Winning musical ANNIE, performing six times, February 14-16, with ...

Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the ...